HOME › DRUGS › LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
ACTIVE SUBSTANCE / INN

LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN

Brand name(s): Pluvicto
EMA LISTED
AUTHORISED
Prostatic Neoplasms, Castration-Resistant
ACTIVE SUBSTANCE
Lutetium (177Lu) Vipivotide Tetraxetan
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PluvictoNovartis Europharm LimitedAuthorised09/12/2022Prostatic Neoplasms, Castration-Resistant

FULL INTELLIGENCE ON LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →